Default Mode Network Modulation by Psychedelics: A Systematic Review
- PMID: 36272145
- PMCID: PMC10032309
- DOI: 10.1093/ijnp/pyac074
Default Mode Network Modulation by Psychedelics: A Systematic Review
Abstract
Psychedelics are a unique class of drug that commonly produce vivid hallucinations as well as profound psychological and mystical experiences. A grouping of interconnected brain regions characterized by increased temporal coherence at rest have been termed the Default Mode Network (DMN). The DMN has been the focus of numerous studies assessing its role in self-referencing, mind wandering, and autobiographical memories. Altered connectivity in the DMN has been associated with a range of neuropsychiatric conditions such as depression, anxiety, post-traumatic stress disorder, attention deficit hyperactive disorder, schizophrenia, and obsessive-compulsive disorder. To date, several studies have investigated how psychedelics modulate this network, but no comprehensive review, to our knowledge, has critically evaluated how major classical psychedelic agents-lysergic acid diethylamide, psilocybin, and ayahuasca-modulate the DMN. Here we present a systematic review of the knowledge base. Across psychedelics there is consistent acute disruption in resting state connectivity within the DMN and increased functional connectivity between canonical resting-state networks. Various models have been proposed to explain the cognitive mechanisms of psychedelics, and in one model DMN modulation is a central axiom. Although the DMN is consistently implicated in psychedelic studies, it is unclear how central the DMN is to the therapeutic potential of classical psychedelic agents. This article aims to provide the field with a comprehensive overview that can propel future research in such a way as to elucidate the neurocognitive mechanisms of psychedelics.
Keywords: DMN; LSD; Psychedelics; ayahuasca; connectivity; psilocybin.
© The Author(s) 2022. Published by Oxford University Press on behalf of CINP.
Figures



Similar articles
-
Serotonergic psychedelics LSD & psilocybin increase the fractal dimension of cortical brain activity in spatial and temporal domains.Neuroimage. 2020 Oct 15;220:117049. doi: 10.1016/j.neuroimage.2020.117049. Epub 2020 Jun 30. Neuroimage. 2020. PMID: 32619708
-
Psychedelics and Hallucinogens in Psychiatry: Finding New Pharmacological Targets.Curr Top Med Chem. 2022;22(15):1250-1260. doi: 10.2174/1568026621666211201145800. Curr Top Med Chem. 2022. PMID: 34852736
-
[Efficacy of psychedelics in psychiatry, a systematic review of the literature].Encephale. 2021 Aug;47(4):376-387. doi: 10.1016/j.encep.2020.12.002. Epub 2021 Apr 20. Encephale. 2021. PMID: 33888297 French.
-
Psilocybin and Other Classic Psychedelics in Depression.Curr Top Behav Neurosci. 2024;66:149-174. doi: 10.1007/7854_2023_451. Curr Top Behav Neurosci. 2024. PMID: 37955822 Review.
-
The psychedelic state induced by ayahuasca modulates the activity and connectivity of the default mode network.PLoS One. 2015 Feb 18;10(2):e0118143. doi: 10.1371/journal.pone.0118143. eCollection 2015. PLoS One. 2015. PMID: 25693169 Free PMC article.
Cited by
-
Mindfulness meditation and psychedelics: potential synergies and commonalities.Pharmacol Rep. 2023 Dec;75(6):1398-1409. doi: 10.1007/s43440-023-00551-8. Epub 2023 Nov 6. Pharmacol Rep. 2023. PMID: 37926796 Free PMC article. Review.
-
Chronic pain as an emergent property of a complex system and the potential roles of psychedelic therapies.Front Pain Res (Lausanne). 2024 Apr 19;5:1346053. doi: 10.3389/fpain.2024.1346053. eCollection 2024. Front Pain Res (Lausanne). 2024. PMID: 38706873 Free PMC article.
-
Long-COVID symptoms improved after MDMA and psilocybin therapy: A case report.Clin Case Rep. 2024 May 28;12(6):e8791. doi: 10.1002/ccr3.8791. eCollection 2024 Jun. Clin Case Rep. 2024. PMID: 38813452 Free PMC article.
-
Psilocybin as Transformative Fast-Acting Antidepressant: Pharmacological Properties and Molecular Mechanisms.Fundam Clin Pharmacol. 2025 Aug;39(4):e70038. doi: 10.1111/fcp.70038. Fundam Clin Pharmacol. 2025. PMID: 40670864 Free PMC article. Review.
-
Psychedelics in developmental stuttering to modulate brain functioning: a new therapeutic perspective?Front Hum Neurosci. 2024 Jun 19;18:1402549. doi: 10.3389/fnhum.2024.1402549. eCollection 2024. Front Hum Neurosci. 2024. PMID: 38962146 Free PMC article.
References
-
- Aday JS, Mitzkovitz CM, Bloesch EK, Davoli CC, Davis AK (2020) Long-term effects of psychedelic drugs: a systematic review. Neurosci Biobehav Rev 113:179–189. - PubMed
-
- Aghajanian GK, Marek GJ (1999) Serotonin-glutamate interactions: a new target for antipsychotic drugs. Neuropsychopharmacol. 6:122–133.
-
- Aleksandrova LR, Phillips AG (2021) Neuroplasticity as a convergent mechanism of ketamine and classical psychedelics. TIPS 11:929–942. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources